Concord Medical Services Holdings (CCM) - Net Assets

Latest as of March 2026: $1.85 Billion USD

Based on the latest financial reports, Concord Medical Services Holdings (CCM) has net assets worth $1.85 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.55 Billion) and total liabilities ($4.70 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CCM tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets $1.85 Billion
% of Total Assets 28.26%
Annual Growth Rate 21.67%
5-Year Change -32.57%
10-Year Change 50.2%
Growth Volatility 223.48

Concord Medical Services Holdings - Net Assets Trend (2007–2025)

This chart illustrates how Concord Medical Services Holdings's net assets have evolved over time, based on quarterly financial data. See Concord Medical Services Holdings defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Concord Medical Services Holdings (2007–2025)

The table below shows the annual net assets of Concord Medical Services Holdings from 2007 to 2025. For live valuation and market cap data, see CCM market cap.

Year Net Assets Change
2025-12-31 $1.85 Billion +14.36%
2024-12-31 $1.62 Billion -7.40%
2023-12-31 $1.75 Billion -13.33%
2022-12-31 $2.02 Billion -26.54%
2021-12-31 $2.74 Billion +14.28%
2020-12-31 $2.40 Billion +27.08%
2019-12-31 $1.89 Billion -16.92%
2018-12-31 $2.27 Billion +124.05%
2017-12-31 $1.01 Billion -17.60%
2016-12-31 $1.23 Billion -14.09%
2015-12-31 $1.43 Billion -20.35%
2014-12-31 $1.80 Billion -26.11%
2013-12-31 $2.44 Billion +4.03%
2012-12-31 $2.34 Billion +14.90%
2011-12-31 $2.04 Billion -11.46%
2010-12-31 $2.30 Billion +6.88%
2009-12-31 $2.15 Billion +281.18%
2008-12-31 $565.02 Million +943.76%
2007-12-31 $54.13 Million --

Equity Component Analysis

This analysis shows how different components contribute to Concord Medical Services Holdings's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 446564300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $105.00K %
Other Comprehensive Income $-75.56 Million %
Other Components $2.44 Billion %
Total Equity $-2.10 Billion 100.00%

Concord Medical Services Holdings Competitors by Market Cap

The table below lists competitors of Concord Medical Services Holdings ranked by their market capitalization.

Company Market Cap
Diversified Gateway Solutions Bhd
KLSE:0131
$14.98 Million
The Western India Plywoods Limited
NSE:WIPL
$14.98 Million
Shape Robotics AS
CO:SHAPE
$14.98 Million
Sungchang Autotech Co. Ltd
KQ:080470
$14.99 Million
Relpol SA
WAR:RLP
$14.97 Million
Bal Pharma Limited
NSE:BALPHARMA
$14.95 Million
CTRL Group Limited Ordinary Shares
NASDAQ:MCTR
$14.94 Million
WhiteSmoke Software Ltd
TA:WSMK
$14.93 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Concord Medical Services Holdings's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -2,280,390,000 to -2,103,110,000, a change of 177,280,000.
  • Net loss of 92,811,000 reduced equity.
  • Other comprehensive income increased equity by 1,784,000.
  • Other factors increased equity by 268,307,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-92.81 Million -4.41%
Other Comprehensive Income $1.78 Million +0.08%
Other Changes $268.31 Million +12.76%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Concord Medical Services Holdings's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-12-31 $0.95 $5.32 x
2008-12-31 $294.89 $5.32 x
2009-12-31 $865.55 $5.32 x
2010-12-31 $452.98 $5.32 x
2011-12-31 $407.97 $5.32 x
2012-12-31 $1322.26 $5.32 x
2013-12-31 $14153.60 $5.32 x
2014-12-31 $11967.70 $5.32 x
2015-12-31 $9300.29 $5.32 x
2016-12-31 $8035.24 $5.32 x
2017-12-31 $6462.53 $5.32 x
2018-12-31 $3025.76 $5.32 x
2019-12-31 $-848.40 $5.32 x
2020-12-31 $54.96 $5.32 x
2021-12-31 $-9410.14 $5.32 x
2022-12-31 $-12801.96 $5.32 x
2023-12-31 $-14573.80 $5.32 x
2024-12-31 $-15662.02 $5.32 x
2025-12-31 $-14442.95 $5.32 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Concord Medical Services Holdings utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -20.15%
  • • Asset Turnover: 0.07x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-5.41%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2008 13.99% 46.03% 0.11x 2.68x $22.57 Million
2009 5.80% 42.69% 0.12x 1.13x $-90.55 Million
2010 5.87% 33.22% 0.15x 1.21x $-91.11 Million
2011 -11.11% -47.77% 0.19x 1.24x $-408.45 Million
2012 6.07% 27.05% 0.13x 1.78x $-79.82 Million
2013 4.04% 15.25% 0.14x 1.92x $-126.55 Million
2014 6.94% 20.55% 0.21x 1.65x $-55.05 Million
2015 -5.63% -12.70% 0.17x 2.59x $-217.34 Million
2016 -22.46% -57.55% 0.14x 2.77x $-378.48 Million
2017 -30.44% -85.90% 0.10x 3.71x $-377.72 Million
2018 -53.70% -123.04% 0.04x 10.48x $-278.62 Million
2019 0.00% -154.79% 0.05x 0.00x $-294.77 Million
2020 -16.83% -181.17% 0.04x 2.22x $-644.11 Million
2021 0.00% -55.89% 0.08x 0.00x $-134.42 Million
2022 0.00% -103.72% 0.08x 0.00x $-303.26 Million
2023 0.00% -55.39% 0.09x 0.00x $-85.46 Million
2024 0.00% -80.28% 0.06x 0.00x $-80.20 Million
2025 0.00% -20.15% 0.07x 0.00x $117.50 Million

Industry Comparison

This section compares Concord Medical Services Holdings's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $533,775,637
  • Average return on equity (ROE) among peers: -361.38%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Concord Medical Services Holdings (CCM) $1.85 Billion 13.99% 2.54x $14.98 Million
Acadia Healthcare Company Inc (ACHC) $1.69 Billion 7.07% 1.54x $1.52 Billion
Addus HomeCare Corporation (ADUS) $970.49 Million 7.58% 0.46x $1.69 Billion
agilon health Inc (AGL) $126.73 Million -319.84% 9.03x $264.44 Million
Airsculpt Technologies Inc (AIRS) $83.99 Million -5.33% 1.43x $348.50 Million
Amedisys Inc (AMED) $810.74 Million 22.65% 0.93x $3.32 Billion
AMN Healthcare Services Inc (AMN) $819.68 Million 8.62% 1.87x $624.22 Million
American Shared Hospital Service (AMS) $15.99 Million 6.89% 1.80x $8.87 Million
American Oncology Network Inc. (AONC) $108.01 Million -3.68% 3.35x $336.36 Million
Ardent Health Partners, Inc. (ARDT) $711.84 Million -20.09% 2.86x $1.28 Billion
Astrana Health Inc (ASTH) $270.37K -3317.63% 75.36x $1.90 Billion

About Concord Medical Services Holdings

NYSE:CCM USA Medical Care Facilities
Market Cap
$14.98 Million
Market Cap Rank
#26002 Global
#5388 in USA
Share Price
$5.32
Change (1 day)
-2.74%
52-Week Range
$3.43 - $6.90
All Time High
$53.10
About

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other tre… Read more